viernes, 23 febrero, 2018
Tratamiento pacientes de cáncer temprano

Celltrion Receives EU Approval for Trastuzumab Biosimilar

NCHEON, South Korea (KRX:068270) announced today that the European Commission (EC) approved Herzuma® (trastuzumab biosimilar) for the treatment of patients with early breast cancer, metastatic...
Cáncer de ovarios

Los padres también transmiten el riesgo de cáncer de ovario

Científicos estadounidenses creen que han identificado una nueva mutación genética que puede aumentar el riesgo de cáncer de ovario y que se transmite de...
La agresividad de la leucemia mieloide aguda

La inmunoterapia ya es primera opción de tratamiento en algunos tumores

La inmunoterapia con anticuerpos que bloquean los receptores PD-1 o la acción sobre estos receptores de la proteína PD-L1 han demostrado eficacia contra un gran número de tumores y ya es la primera opción...
Oncology: International Journal of Cancer Research and Treatment

Surgical Treatment following Chemo-Targeted Therapy with Bevacizumab for Lung Metastasis from Colorectal Carcinoma: Analysis...

Oncology: International Journal of Cancer Research and Treatment Published online: January – April 2018 DOI: https://doi.org/10.1159/000486825 Nakagiri T.a · Tokunaga T.a · Kunoh H.a · Noura S.b · Ishida H.a · Miyoshi N.b · Ohue M.b · Okami J.a· Higashiyama M.a  Background: Recently, therapeutic strategies for...
international-journal-oncology-cancer-research

Long-Lasting Response to Trabectedin in a Patient with Metastatic Uterine Leiomyosarcoma: A Case Report

Oncology: International Journal of Cancer Research and Treatment Published online: January – April 2018 DOI: https://doi.org/10.1159/000486638 Nteli V.-A.a · Knauf W.b · Janton-Klein A.a · El-Safadi S.a  Background: Uterine leiomyosarcoma (uLMS) is a rare tumor that accounts...

TIM-3 Regulates CD103+ Dendritic Cell Function and Response to Chemotherapy in Breast Cancer

Cancer Cell First published:  January 8, 2018 DOI: https://doi.org/10.1016/j.ccell.2017.11.019 Álvaro de Mingo Pulido, Alycia Gardner, Shandi Hiebler, Hatem Soliman, Hope S. Rugo, Matthew F. Krummel, Lisa M. Coussens, Brian...

Cooperative Epigenetic Remodeling by TET2 Loss and NRAS Mutation Drives Myeloid Transformation and MEK...

Cancer Cell First published:  December 21, 2017 DOI: https://doi.org/10.1016/j.ccell.2017.11.012 Hiroyoshi Kunimoto, Cem Meydan, Abbas Nazir, Justin Whitfield, Kaitlyn Shank, Franck Rapaport, Rebecca Maher, Elodie Pronier, Sara C. Meyer, Francine...
PORTADA-THELANCETONCOLOGY-Febrero2018

Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk,...

The Lancet Oncology Published: 17 January 2018 DOI: https://doi.org/10.1016/S1470-2045(18)30015-9 Rodabe N Amaria, MD*, Peter A Prieto, MD*, Michael T Tetzlaff, MD, Alexandre Reuben, PhD, Miles C Andrews, PhD, Prof...